Skip to main content
Article
Retrospective Review of Maternal and Fetal Outcomes in Patients With Gestational Diabetes Mellitus in an Indigent Prenatal Clinic.
Diabetes Spectrum
  • Sara Wilson Reece, Philadelphia College of Osteopathic Medicine
  • Harish S. Parihar, Philadelphia College of Osteopathic Medicine
  • Mark Martinez
Document Type
Article
Publication Date
5-1-2018
Abstract

Gestational diabetes mellitus (GDM) is diabetes that is diagnosed during the second or third trimester of pregnancy and is not clearly overt diabetes (1). Diagnosis is defined by severity of carbohydrate intolerance. The upper end of the GDM diagnostic glucose range is the same as would be indicative of diabetes outside of pregnancy, whereas the lower end of the GDM range is only slightly above normal and asymptomatic but still associated with increased risk of fetal morbidity (1,2). Diabetes during pregnancy is diagnosed by either a one-step approach involving a 75-g oral glucose tolerance test (OGTT) or a two-step approach starting with a 50-g (nonfasting) screen followed by a 100-g OGTT for those who initially screen positive (1). Glycemic goals for patients with a GDM diagnosis are as follows: preprandial ≤95 mg/dL and either 1-hour postprandial ≤140 mg/dL or 2-hour postprandial ≤120 mg/dL.

PubMed ID
29773943
Comments

This article was published in Diabetes Spectrum, Volume 31, Issue 2, Pages 200-205.

The published version is available at https://doi.org/10.2337/ds17-0002.

Copyright © 2018 American Diabetes Association.

Citation Information
Sara Wilson Reece, Harish S. Parihar and Mark Martinez. "Retrospective Review of Maternal and Fetal Outcomes in Patients With Gestational Diabetes Mellitus in an Indigent Prenatal Clinic." Diabetes Spectrum Vol. 31 Iss. 2 (2018) p. 200 - 205
Available at: http://works.bepress.com/sara_reece/21/